Menu Search
Equities

Philip Morris CR as

0MV4:LSE

Philip Morris CR as

Actions
  • Price (CZK)15,854.48
  • Today's Change0.00 / 0.00%
  • Shares traded5.00
  • 1 Year change-10.48%
  • Beta--
Data delayed at least 20 minutes, as of Apr 26 2024 17:45 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Philip Morris CR as is a Czech Republic based company active in the tobacco industry. The Company is engaged in the production, sale, distribution and marketing of tobacco products. Together with its subsidiary Philip Morris Slovakia sro, it produces, sells and distributes its products in the Czech Republic and Slovakia. It provides customers with several international and local cigarette brands, such as Marlboro, L&M, Red & White, Petra and Sparta, among others, in different variants, tastes and price segments, as well as roll-your-own tobacco. The Company owns a manufacturing facility in Kutna Hora, the Czech Republic. The Company is a member of a Philip Morris International Inc, and its major shareholder is Philip Morris Holdings BV.

  • Revenue in CZK (TTM)20.57bn
  • Net income in CZK3.34bn
  • Incorporated1991
  • Employees1.30k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.